Harry Lander

712 total citations
41 papers, 539 citations indexed

About

Harry Lander is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Harry Lander has authored 41 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Harry Lander's work include Venous Thromboembolism Diagnosis and Management (4 papers), Hemoglobinopathies and Related Disorders (4 papers) and Blood transfusion and management (3 papers). Harry Lander is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (4 papers), Hemoglobinopathies and Related Disorders (4 papers) and Blood transfusion and management (3 papers). Harry Lander collaborates with scholars based in Australia, United Kingdom and Canada. Harry Lander's co-authors include Matthew G. Davey, D. J. Deller, José M. Bonnin, D. A. Simpson, J. V. Lloyd, Peter S. Davis, Basil S. Hetzel, David J. Cook, John J. McNeil and Robert D. Goldney and has published in prestigious journals such as Nature, The American Journal of Medicine and American Journal of Roentgenology.

In The Last Decade

Harry Lander

40 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harry Lander Australia 14 99 95 91 90 71 41 539
L. T. Archer United States 15 89 0.9× 102 1.1× 246 2.7× 120 1.3× 53 0.7× 36 627
L Revert Spain 12 70 0.7× 50 0.5× 70 0.8× 180 2.0× 29 0.4× 33 503
Dean A. Arvan United States 13 41 0.4× 162 1.7× 68 0.7× 57 0.6× 38 0.5× 31 544
F Streiff France 10 95 1.0× 39 0.4× 85 0.9× 64 0.7× 45 0.6× 108 444
Edward Adelson United States 15 357 3.6× 82 0.9× 42 0.5× 130 1.4× 76 1.1× 24 779
Arnold G. Ware United States 13 206 2.1× 53 0.6× 23 0.3× 62 0.7× 29 0.4× 30 578
Ralph M. Myerson United States 17 81 0.8× 136 1.4× 113 1.2× 114 1.3× 95 1.3× 58 768
I. Witt Germany 13 353 3.6× 84 0.9× 41 0.5× 246 2.7× 92 1.3× 60 781
S. D. Mohamed United Kingdom 9 113 1.1× 244 2.6× 66 0.7× 52 0.6× 64 0.9× 16 700
K. Jaschonek Germany 13 117 1.2× 120 1.3× 59 0.6× 52 0.6× 56 0.8× 35 574

Countries citing papers authored by Harry Lander

Since Specialization
Citations

This map shows the geographic impact of Harry Lander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Lander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Lander more than expected).

Fields of papers citing papers by Harry Lander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Lander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Lander. The network helps show where Harry Lander may publish in the future.

Co-authorship network of co-authors of Harry Lander

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Lander. A scholar is included among the top collaborators of Harry Lander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Lander. Harry Lander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petrushina, Irina, Armine Hovakimyan, Hayk Davtyan, et al.. (2020). Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials. Neurobiology of Disease. 139. 104823–104823. 34 indexed citations
2.
Lander, Harry. (1984). Some medical aspects of euthanasia*. The Medical Journal of Australia. 141(3). 173–177. 2 indexed citations
3.
Ronai, Peter, et al.. (1975). Technetium/sup 99m/-pyridoxylideneglutamate: a new hapatobiliary radiopharmaceutical. II. Clinical aspects. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 2 indexed citations
4.
Lloyd, J. V., et al.. (1972). Platelet ascorbic acid levels in normal subjects and in disease. Journal of Clinical Pathology. 25(6). 478–483. 20 indexed citations
5.
Cook, David J. & Harry Lander. (1971). The diagnosis of pulmonary embolism: a review with particular reference to the use of radionuclides. Postgraduate Medical Journal. 47(546). 214–226. 3 indexed citations
6.
Lander, Harry, et al.. (1970). Disseminated Histoplasmosis. Australasian Annals of Medicine. 19(2). 151–158. 12 indexed citations
7.
Davey, Matthew G. & Harry Lander. (1968). Effect of injected heparin on platelet levels in man. Journal of Clinical Pathology. 21(1). 55–59. 42 indexed citations
8.
Lander, Harry, et al.. (1966). An Evaluation of Anticoagulant Solutions Used in the Preparation of Platelet Concentrates*. Transfusion. 6(3). 213–223. 6 indexed citations
9.
Bennett, R. C., et al.. (1966). THE PLACE OF SPLENECTOMY IN HAEMATOLOGICAL DISORDERS: THE VALUE OF 51 Cr TECHNIQUES. The Medical Journal of Australia. 2(22). 1022–1027. 9 indexed citations
10.
Kimber, Richard, et al.. (1965). THE SEQUESTRATION OF NEM-TREATED RED CELLS IN NORMAL AND ABNORMAL SUBJECTS: A TEST OF SPLENIC UPTAKE FUNCTION.. PubMed. 65. 951–66. 13 indexed citations
11.
Davey, Matthew G. & Harry Lander. (1965). POTASSIUM AND ACID PHOSPHATASE LEVELS IN SERUM AND PLASMA OF PATIENTS WITH HIGH PLATELET COUNTS. The Medical Journal of Australia. 1(8). 272–273. 2 indexed citations
12.
Davey, Matthew G. & Harry Lander. (1964). Effect of Adenosine Diphosphate on Circulating Platelets in Man. Nature. 201(4923). 1037–1039. 32 indexed citations
13.
Cooper, DW, Harry Lander, & R. L. Kirk. (1964). DAdelaide—a New Transferrin Variant in Man. Nature. 204(4953). 102–102. 5 indexed citations
14.
Lander, Harry & Matthew G. Davey. (1964). THE BEHAVIOUR AND SURVIVAL OF PLATELETS IN POLYCYTHÆMIA AND THROMBOCYTHÆMIA. Australasian Annals of Medicine. 13(3). 207–216. 12 indexed citations
15.
Lander, Harry, et al.. (1963). THE LABELLING OF HUMAN PLATELETS WITH RADIOCHROMATE. Immunology and Cell Biology. 41(6). 581–593. 17 indexed citations
16.
Lander, Harry. (1963). INSTRUMENTS USED FOR GASTRO‐INTESTINAL BIOPSY. Australasian Annals of Medicine. 12(3). 238–250. 3 indexed citations
17.
Simpson, D. A., et al.. (1959). OBSERVATIONS ON KURU: II. CLINICAL FEATURES. Australasian Annals of Medicine. 8(1). 8–15. 23 indexed citations
18.
Lander, Harry. (1958). ACUTE HÆMORRHAGIC LEUCO‐ENCEPHALITIS. Australasian Annals of Medicine. 7(1). 55–68. 4 indexed citations
19.
Hetzel, Basil S., et al.. (1957). Immediate Treatment of Apoplexy. BMJ. 1(5027). 1122–1122. 11 indexed citations
20.
Lander, Harry & José M. Bonnin. (1956). Giant‐cell arteritis. Report of a case with autopsy. The Journal of Pathology and Bacteriology. 71(2). 369–373. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026